The heritability and genetics of frontotemporal lobar degeneration

Background: Frontotemporal lobar degeneration (FTLD) is a genetically and pathologically heterogeneous neurodegenerative disorder. Methods: We collected blood samples from a cohort of 225 patients with a diagnosis within the FTLD spectrum and examined the heritability of FTLD by giving each patient a family history score, from 1 (a clear autosomal dominant history of FTLD) through to 4 (no family history of dementia). We also looked for mutations in each of the 5 disease-causing genes (MAPT, GRN, VCP, CHMP2B, and TARDP) and the FUS gene, known to cause motor neuron disease. Results: A total of 41.8% of patients had some family history (score of 1, 2, 3, or 3.5), although only 10.2% had a clear autosomal dominant history (score of 1). Heritability varied across the different clinical subtypes of FTLD with the behavioral variant being the most heritable and frontotemporal dementia–motor neuron disease and the language syndromes (particularly semantic dementia) the least heritable. Mutations were found in MAPT (8.9% of the cohort) and GRN (8.4%) but not in any of the other genes. Of the remaining patients without mutations but with a strong family history, 7 had pathologic confirmation, falling into 2 groups: type 3 FTLD-TDP without GRN mutations (6) and FTLD-UPS (1). Conclusion: These findings show that frontotemporal lobar degeneration (FTLD) is a highly heritable disorder but heritability varies between the different syndromes. Furthermore, while MAPT and GRN mutations account for a substantial proportion of familial cases, there are other genes yet to be discovered, particularly in patients with type 3 FTLD-TDP without a GRN mutation.

[1]  S. Mead,et al.  Corticobasal syndrome associated with a novel 1048_1049insG progranulin mutation , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[2]  D. Dickson,et al.  Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes , 2009, Acta Neuropathologica.

[3]  S. Heath,et al.  Chromosome 9p-linked families with frontotemporal dementia associated with motor neuron disease , 2009, Neurology.

[4]  B. Dubois,et al.  TARDBP mutations in motoneuron disease with frontotemporal lobar degeneration , 2009, Annals of neurology.

[5]  G. Binetti,et al.  Progranulin Leu271LeufsX10 is one of the most common FTLD and CBS associated mutations worldwide , 2009, Neurobiology of Disease.

[6]  Xun Hu,et al.  Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.

[7]  J L Haines,et al.  Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .

[8]  John L. Robinson,et al.  Clinical and pathological continuum of multisystem TDP-43 proteinopathies. , 2009, Archives of neurology.

[9]  W. Kamphorst,et al.  Distinct genetic forms of frontotemporal dementia , 2008, Neurology.

[10]  B. Miller,et al.  The logopenic/phonological variant of primary progressive aphasia , 2008, Neurology.

[11]  H. Kretzschmar,et al.  TDP-43-negative FTLD-U is a significant new clinico-pathological subtype of FTLD , 2008, Acta Neuropathologica.

[12]  Nancy Johnson,et al.  Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia , 2008, Annals of neurology.

[13]  I. Mackenzie,et al.  Atypical frontotemporal lobar degeneration with ubiquitin-positive, TDP-43-negative neuronal inclusions. , 2008, Brain : a journal of neurology.

[14]  Carlo Caltagirone,et al.  Progranulin genetic variations in frontotemporal lobar degeneration: evidence for low mutation frequency in an Italian clinical series , 2008, Neurogenetics.

[15]  Andrew King,et al.  A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. , 2008, Brain : a journal of neurology.

[16]  Julie S Snowden,et al.  Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. , 2008, Brain : a journal of neurology.

[17]  J. Trojanowski,et al.  Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations , 2008, Acta Neuropathologica.

[18]  I. Mackenzie,et al.  The molecular genetics and neuropathology of frontotemporal lobar degeneration: recent developments , 2007, Neurogenetics.

[19]  B. Dubois,et al.  Progranulin null mutations in both sporadic and familial frontotemporal dementia , 2007, Human mutation.

[20]  J. Schneider,et al.  Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration , 2007, Acta Neuropathologica.

[21]  David Mann,et al.  Frontotemporal lobar degeneration: clinical and pathological relationships , 2007, Acta Neuropathologica.

[22]  R. Petersen,et al.  Neuropathologic Features of Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions With Progranulin Gene (PGRN) Mutations , 2007, Journal of neuropathology and experimental neurology.

[23]  S. Melquist,et al.  Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. , 2006, Human molecular genetics.

[24]  C. Duijn,et al.  Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21 , 2006, Nature.

[25]  J. Neuhaus,et al.  Comparison of family histories in FTLD subtypes and related tauopathies , 2005, Neurology.

[26]  Erdahl T. Teber,et al.  Frequency of tau mutations in familial and sporadic frontotemporal dementia and other tauopathies , 2004, Journal of Neurology.

[27]  G. Binetti,et al.  Prevalence of pathogenic mutations in an Italian clinical series of patients with familial dementia. , 2004, Current Alzheimer research.

[28]  M. Weiner,et al.  Cognition and anatomy in three variants of primary progressive aphasia , 2004, Annals of neurology.

[29]  J. Trojanowski,et al.  Evidence of a founder effect in families with frontotemporal dementia that harbor the tau +16 splice mutation , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[30]  Philip Scheltens,et al.  Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. , 2003, Brain : a journal of neurology.

[31]  R. Uitti,et al.  Clinical features of frontotemporal dementia due to the intronic tau 10+16 mutation , 2003, Neurology.

[32]  Irene Litvan,et al.  Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia , 2003, Annals of neurology.

[33]  Catherine Lomen-Hoerth,et al.  The overlap of amyotrophic lateral sclerosis and frontotemporal dementia , 2002, Neurology.

[34]  Nick C Fox,et al.  Clinical features of frontotemporal dementia due to the intronic tau 10+16 mutation , 2002, Neurology.

[35]  P. Lantos,et al.  A novel tau mutation (N296N) in familial dementia with swollen achromatic neurons and corticobasal inclusion bodies , 2000, Annals of neurology.

[36]  R. Faber,et al.  Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.

[37]  R. Petersen,et al.  Frequency of tau mutations in three series of non‐Alzheimer's degenerative dementia , 1999, Annals of neurology.

[38]  A. Kertesz,et al.  Clinical and Pathological Overlap between Frontotemporal Dementia, Primary Progressive Aphasia and Corticobasal Degeneration: The Pick Complex , 1999, Dementia and Geriatric Cognitive Disorders.

[39]  D. Geschwind,et al.  Inheritance of frontotemporal dementia. , 1999, Archives of neurology.

[40]  M. Hallett,et al.  Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) , 1996, Neurology.